Provided by Tiger Fintech (Singapore) Pte. Ltd.

CLOUDBREAK-B

5.990
+0.0200.34%
Volume:500.00
Turnover:3.00K
Market Cap:5.02B
PE:-3.66
High:5.990
Open:5.990
Low:5.990
Close:5.970
Loading ...

Company Profile

Company Name:
CLOUDBREAK-B
Exchange:
SEHK
Establishment Date:
2015
Employees:
51
Office Location:
8921 Research Drive,Irvine,California,United States
Zip Code:
92618
Phone:
- -
Fax:
- -
Introduction:
Cloudbreak Pharma is a clinical-stage ophthalmic drug company. The company was founded in Irvine, California in September 2015. Our team has diverse skills and rich experience in ophthalmic drug development. Our eyes are more than just a visual tool. We connect and communicate with people and the world around us through our eyes. Baokang Vision Cloud's mission is to ensure that no one is hindered by poor eye health. Our goal is to help people enjoy life better by treating various eye diseases that impair vision and quality of life. We are a clinical-stage global biotech company developing ophthalmic medicines to treat chronic eye diseases where treatment options are often scarce. Our broad product line has been developed by in-house scientists with the experience and expertise to discover novel mechanisms of action and formulations suitable for topical ocular administration. Our in-depth understanding of the pathogenesis of ophthalmic diseases and our extensive scientific knowledge led us to develop our main candidate product, CBT-001, a research-stage eye drop treatment that has the potential to slow or stop the progression of pterygium, a highly underdiagnosed and undertreated disease for which there is no approved drug treatment.

Directors

Name
Position
NI Jinsong
Chairman of the Board,Executive Director
Van Son DINH
Executive Director
YANG Rong
Executive Director
LAI Hin Wing Henry
Independent Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee,Audit Committee Member
LIAO Zhong Min
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
NIE Si Jiang
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
LI Jun Zhi
Director
CAO Xu
Director
XIA Zhi Dong
Director

Shareholders

Name
Position
NI Jinsong
CEO
CHEN Qing Zhu
CFO
FENG Ya Fang
CFO,Corporate Secretary
Elizabeth Sharon CAPAN
Compliance Director,Other Senior Executives
Van Son DINH
Senior Technical Personnel
YANG Rong
Chief Science Officer
Abu P ABRAHAM
Other Senior Executives
FANG Wenkui Ken
Other Senior Executives